Sox10—A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue: A Systematic Analysis of 5134 Tumors

Sox10 transcription factor is expressed in schwannian and melanocytic lineages and is important in their development and can be used as a marker for corresponding tumors. In addition, it has been reported in subsets of myoepithelial/basal cell epithelial neoplasms, but its expression remains incompletely characterized. In this study, we examined Sox10 expression in 5134 human neoplasms spanning a wide spectrum of neuroectodermal, mesenchymal, lymphoid, and epithelial tumors. A new rabbit monoclonal antibody (clone EP268) and Leica Bond Max automation were used on multitumor block libraries containing 30 to 70 cases per slide. Sox10 was consistently expressed in benign Schwann cell tumors of soft tissue and the gastrointestinal tract and in metastatic melanoma and was variably present in malignant peripheral nerve sheath tumors. In contrast, Sox10 was absent in many potential mimics of nerve sheath tumors such as cellular neurothekeoma, meningioma, gastrointestinal stromal tumors, perivascular epithelioid cell tumor and a variety of fibroblastic-myofibroblastic tumors. Sox10 was virtually absent in mesenchymal tumors but occasionally seen in alveolar rhabdomyosarcoma. In epithelial tumors of soft tissue, Sox10 was expressed only in myoepitheliomas, although often absent in malignant variants. Carcinomas, other than basal cell–type breast cancers, were only rarely positive but included 6% of squamous carcinomas of head and neck and 7% of pulmonary small cell carcinomas. Furthermore, Sox10 was often focally expressed in embryonal carcinoma reflecting a primitive Sox10-positive phenotype or neuroectodermal differentiation. Expression of Sox10 in entrapped non-neoplastic Schwann cells or melanocytes in various neoplasms has to be considered in diagnosing Sox10-positive tumors. The Sox10 antibody belongs in a modern immunohistochemical panel for the diagnosis of soft tissue and epithelial tumors.

[1]  E. Zwarthoff,et al.  TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors , 2014, Journal of Neuro-Oncology.

[2]  Cynthia Cohen,et al.  SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues , 2013, Applied immunohistochemistry & molecular morphology : AIMM.

[3]  K. Busam.  Molecular pathology of melanocytic tumors. , 2013, Seminars in diagnostic pathology.

[4]  H. Okano,et al.  SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis , 2013, Modern Pathology.

[5]  N. Ordóñez.  Value of SOX10 Immunostaining in Tumor Diagnosis , 2013, Advances in anatomic pathology.

[6]  S. Dry,et al.  SOX10 Expression Distinguishes Desmoplastic Melanoma From Its Histologic Mimics , 2013, The American Journal of dermatopathology.

[7]  M. Prasad,et al.  Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas , 2013, British Journal of Cancer.

[8]  J. Taube,et al.  Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. , 2013, Human pathology.

[9]  A. Suurmeijer,et al.  Sox10 immunohistochemistry allows the pathologist to differentiate between prototypical granular cell tumors and other granular cell lesions , 2012, Histopathology.

[10]  J. Taube,et al.  Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses. , 2012, Journal of the American Academy of Dermatology.

[11]  R. West,et al.  Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[12]  M. Miettinen.  A Simple Method for Generating Multitissue Blocks Without Special Equipment , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[13]  K. Olsen,et al.  Low-grade Sinonasal Sarcoma With Neural and Myogenic Features: A Clinicopathologic Analysis of 28 Cases , 2012, The American journal of surgical pathology.

[14]  S. Raimondi,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathologic, Proteomic, and Genomic Study , 2011, The American journal of surgical pathology.

[15]  R. Bakos,et al.  Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma , 2009, Experimental dermatology.

[16]  L. Chiriboga,et al.  Sox10: A Pan-Schwannian and Melanocytic Marker , 2008, The American journal of surgical pathology.

[17]  S. Tripp,et al.  Malignant Peripheral Nerve Sheath Tumor: A Comparison of Grade, Immunophenotype, and Cell Cycle/Growth Activation Marker Expression in Sporadic and Neurofibromatosis 1-Related Lesions , 2003, The American journal of surgical pathology.

[18]  M. Wegner,et al.  Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. , 2001, Development.

[19]  S. Florell,et al.  Basal Cell Carcinomas Are Populated By Melanocytes and Langerhan's Cells , 2001 .

[20]  B. Roe,et al.  The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor , 1998, Human Genetics.

[21]  M. Wegner,et al.  Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Giovanni Romeo,et al.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease , 1998, Nature Genetics.

[23]  M. Wegner,et al.  Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.

[24]  Y. Ohtsuki,et al.  Immunohistochemical study on the distribution of α and β subunits of S-100 protein in brain tumors , 2004, Acta Neuropathologica.

[25]  Y. Ohtsuki,et al.  Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in brain tumors. , 1991, Acta Neuropathologica.